Lipolysis

Also known as: Lipolysis · Fat breakdown (colloquial) · Lipid hydrolysis

Definition

Lipolysis is the metabolic process by which triglycerides (stored fat) are hydrolyzed into glycerol and free fatty acids for use as energy substrates by the body. Lipolysis occurs primarily in adipose tissue (fat cells/adipocytes) and is regulated by hormonal signals — most importantly catecholamines (epinephrine, norepinephrine) which stimulate lipolysis, and insulin which inhibits it. In clinical and aesthetic medicine contexts, “lipolysis” also refers to therapeutic procedures designed to reduce localized fat deposits — including injection lipolysis (phosphatidylcholine/deoxycholate injections), laser-assisted lipolysis, cryolipolysis (fat freezing), and ultrasound-assisted lipolysis. These aesthetic procedures are distinct from the endogenous metabolic process but share the conceptual framework of breaking down triglycerides. (Wikipedia — Lipolysis)

Identities

Source Type	Identity
Wikipedia	Lipolysis
Wikidata	Lipolysis (Q3130)
DBpedia	N/A
ProductOntology	N/A
Wiktionary	lipolysis
LCSH	Lipolysis / Adipose tissue — Metabolism
MeSH	Lipolysis
NCBI Taxonomy	N/A
AGROVOC	N/A
Google Scholar	lipolysis mechanism fat metabolism catecholamines insulin
ConceptNet	N/A
OpenCyc	N/A

Also Known As

Lipolysis
Fat breakdown (colloquial)
Lipid hydrolysis

Usage Scenarios

1. Endogenous Metabolic Lipolysis

During fasting or exercise, catecholamines stimulate adipose-tissue lipolysis — releasing free fatty acids for energy use by muscle, liver, and other tissues. Insulin (elevated after eating) suppresses lipolysis.

2. Injection Lipolysis (Aesthetic)

Phosphatidylcholine/deoxycholate injections dissolve small localized fat deposits (double chin, jowls, abdominal pooch). ATX-101 (Kybella) is the FDA-approved injectable for submental fat.

3. Cryolipolysis (Aesthetic)

Controlled cold exposure (e.g., CoolSculpting) induces adipocyte apoptosis in targeted areas. Non-surgical fat reduction.

4. Pharmacologically Enhanced Lipolysis

Compounds like yohimbine, caffeine, and synthetic beta-agonists stimulate lipolysis via adrenergic pathways — marketed for weight management but with limited clinical evidence.

Strategies

Distinguish metabolic lipolysis (endogenous process) from aesthetic lipolysis (therapeutic procedures)
For aesthetic fat reduction: physician-supervised only, FDA-registered devices
For metabolic optimization: exercise + nutrition + sleep regulation of insulin/catecholamine balance

Security and Safety Measures

Aesthetic lipolysis procedures: verify FDA product/device registration
Verify physician credentialing
Avoid compounded injection lipolysis sold through unauthorized channels

Historical Context

The biochemistry of lipolysis was elucidated in the mid-20th century. Aesthetic lipolysis procedures emerged in the 2000s–2010s with cryolipolysis and injection lipolysis expanding the non-surgical fat-reduction market.

Challenges and Controversies

Compounded Injection Lipolysis Safety

Compounded lipolytic injections sold through Philippine aesthetic clinics and social media bypass FDA product-registration requirements.

Evidence Base

Many aesthetic lipolysis devices have limited long-term clinical evidence relative to surgical liposuction.

Off-Label Use

Some aesthetic lipolysis products are used off-label beyond FDA-approved indications.

References

Wikipedia — Lipolysis